XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities:    
Net income (loss) $ (419) $ (253)
Adjustments to reconcile net income (loss) to net cash provided by operations:    
Depreciation and amortization 272 304
Impairment of goodwill, long-lived assets and assets held for sale 679 189
Net change in operating assets and liabilities (497) (349)
Deferred income taxes – net and uncertain tax positions (189) (106)
Stock-based compensation 28 32
Other items 2 34
Net loss (gain) from investments and from sale of long lived assets 0 4
Net cash provided by (used in) operating activities (124) (145)
Investing activities:    
Beneficial interest collected in exchange for securitized trade receivables 295 323
Purchases of property, plant and equipment and intangible assets (124) (139)
Proceeds from sale of business and long lived assets 0 2
Acquisition of businesses, net of cash acquired (15) 0
Purchases of investments and other assets (12) (4)
Other investing activities 0 (1)
Net cash provided by (used in) investing activities 144 181
Financing activities:    
Purchase of shares from non-controlling interests (64) 0
Dividends paid to non-controlling interests (78) 0
Repayment of senior notes and loans and other long term liabilities 0 (3,152)
Proceeds from senior notes, net of issuance costs 0 2,451
Other financing activities (9) (5)
Net cash provided by (used in) financing activities (151) (706)
Translation adjustment on cash and cash equivalents (104) 12
Net change in cash, cash equivalents and restricted cash (236) (658)
Balance of cash, cash equivalents and restricted cash at beginning of period 3,227 2,834
Balance of cash, cash equivalents and restricted cash at end of period 2,991 2,176
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 2,991 2,143
Restricted cash included in other current assets 0 33
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 2,991 2,176
Non-cash financing and investing activities:    
Beneficial interest obtained in exchange for securitized accounts receivables $ 312 $ 334